Drug General Information
Drug ID	D00HVX
Former ID	DNC005878
Drug Name	[1,2,4]triazolo[1,5-a]quinoxalin-4(5H)-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527915]
Structure		Download 2D MOL 3D MOL
Formula	C9H6N4O
Canonical SMILES	C1=CC=C2C(=C1)NC(=O)C3=NC=NN23
InChI	1S/C9H6N4O/c14-9-8-10-5-11-13(8)7-4-2-1-3-6(7)12-9/h1-5H,(H,12,14)
InChIKey	OEIMIUHARCZWJY-UHFFFAOYSA-N
PubChem Compound ID	10103893
Target and Pathway
Target(s)	Adenosine A3 receptor	Target Info	Inhibitor	[527915]
Reactome	Adenosine P1 receptors
	G alpha (i) signalling events
WikiPathways	Nucleotide GPCRs
	GPCRs, Class A Rhodopsin-like
	GPCRs, Other
References
Ref 527915	J Med Chem. 2005 Dec 15;48(25):7932-45.1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
Ref 527915	J Med Chem. 2005 Dec 15;48(25):7932-45.1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.